ROVALCYTE Side Effects

6268744-7 | Renal Failure Acute
on Jul 01, 2009 Male patient from FRANCE , 52 years of age, was diagnosed with organ transplant (What is organ transplant?) and was treated with Rovalcyte (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute. Rovalcyte dosage: .

5843493-5 | Central Line Infection, Dermatitis Exfoliative, Dysphagia, Enterococcal Infection, Escherichia Bacteraemia, Lymphangitis, Metabolic Acidosis, Pyrexia, Rash Scarlatiniform
Patient was taking Rovalcyte (View Usage). Patient had the following side effects: central line infection, dermatitis exfoliative, dysphagia, enterococcal infection, escherichia bacteraemia, lymphangitis, metabolic acidosis, pyrexia, rash scarlatiniform on Jul 29, 2008 from UNITED STATES Additional patient health information: Male patient , 45 years of age, was diagnosed with neutropenia and. Rovalcyte dosage: . During the same period patient was treated with NEUPOGEN (Form Reported: Pre-filled Syringe) (View Neupogen Review and Neupogen Label ), TEICOPLANIN (View Teicoplanin Review and Teicoplanin Label ), ABACAVIR SULFATE LAMIVUDINE AND ZIDOVUDINE (View Abacavir Sulfate Lamivudine And Zidovudine Review and Abacavir Sulfate Lamivudine And Zidovudine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), DARUNAVIR (View Darunavir Review and Darunavir Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), BROMAZEPAM (View Bromazepam Review and Bromazepam Label ). Patient was hospitalized.

5840028-8 | Central Line Infection, Dermatitis Exfoliative, Dysphagia, Enterococcal Infection, Escherichia Bacteraemia, Lymphangitis, Metabolic Acidosis, Pyrexia, Rash Scarlatiniform
Adverse event was reported on Jul 29, 2008 by a Male patient taking Rovalcyte (View Usage) (Dosage: ) was diagnosed with neutropenia and. Location: UNITED STATES , 45 years of age, After Rovalcyte was administered, patient had the following side effects: central line infection, dermatitis exfoliative, dysphagia, enterococcal infection, escherichia bacteraemia, lymphangitis, metabolic acidosis, pyrexia, rash scarlatiniform. During the same period patient was treated with NEUPOGEN (Form Reported: Pre-filled Syringe) (View Neupogen Review and Neupogen Label ), TEICOPLANIN (View Teicoplanin Review and Teicoplanin Label ), ABACAVIR SULFATE LAMIVUDINE AND ZIDOVUDINE (View Abacavir Sulfate Lamivudine And Zidovudine Review and Abacavir Sulfate Lamivudine And Zidovudine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), DARUNAVIR (View Darunavir Review and Darunavir Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), BROMAZEPAM (View Bromazepam Review and Bromazepam Label ). Patient was hospitalized.

5780030-8 | Pancreatitis
on Jun 11, 2008 Male patient from FRANCE , 73 years of age, was diagnosed with lymphoma (What is lymphoma?) and was treated with Rovalcyte (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis. Rovalcyte dosage: . During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), EFFEXOR (View Effexor Review and Effexor Label ), ANTALGIC (View Antalgic Review and Antalgic Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.


5759959-2 | Deafness
on May 28, 2008 Female patient from FRANCE , weighting 103.6 lb, was treated with Rovalcyte (View Usage). Patient had the following side effects: deafness. Rovalcyte dosage: . During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), NEXIUM (View Nexium Review and Nexium Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), PROGRAF (View Prograf Review and Prograf Label ).

5565368-1 | Cardiac Arrest, Herpes Virus Infection, Hypoxia, Neutropenia, Respiratory Distress, Tachypnoea
Patient was taking Rovalcyte (View Usage). After Rovalcyte was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), herpes virus infection, hypoxia, neutropenia, respiratory distress, tachypnoea on Jul 19, 2004 from FRANCE Additional patient health information: Male patient , 35 years of age, weighting 176.4 lb, was diagnosed with prophylaxis and. Rovalcyte dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), BACTRIM (View Bactrim Review and Bactrim Label ), RIFATER (View Rifater Review and Rifater Label ), OFLOCET (View Oflocet Review and Oflocet Label ), TAZOCILLINE (View Tazocilline Review and Tazocilline Label ), KALETRA (View Kaletra Review and Kaletra Label ). Patient was hospitalized.

5546780-3 | Bone Marrow Failure
Adverse event was reported on Nov 29, 2007 by a Female patient taking Rovalcyte (View Usage) (Dosage: ) was diagnosed with transplant and. Location: FRANCE , 49 years of age, Patient experienced the following unwanted or unexpected effects: bone marrow failure. During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ), INIPOMP (View Inipomp Review and Inipomp Label ), DELURSAN (Dose Reported As 250 Twice) (View Delursan Review and Delursan Label ), TARDYFERON (View Tardyferon Review and Tardyferon Label ), FRAXIPARINE (View Fraxiparine Review and Fraxiparine Label ).

5427791-5 | Agranulocytosis
on Aug 17, 2007 Female patient from FRANCE , 64 years of age, weighting 103.6 lb, was treated with Rovalcyte (View Usage). Patient had the following side effects: agranulocytosis. Rovalcyte dosage: Dose Reduced To Half. During the same period patient was treated with SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ). Patient was hospitalized.

5423866-5 | Rash Maculo-papular, Skin Exfoliation, Toxic Skin Eruption
on Aug 09, 2007 Male patient from UNITED STATES , 46 years of age, was treated with Rovalcyte (View Usage). After Rovalcyte was administered, patient had the following side effects: rash maculo-papular, skin exfoliation, toxic skin eruption. Rovalcyte dosage: Given Two Tablets Daily.. During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), KALETRA (View Kaletra Review and Kaletra Label ). Patient was hospitalized.

5311586-7 | Agranulocytosis
Patient was taking Rovalcyte (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis on Apr 16, 2007 from FRANCE Additional patient health information: Female patient , 64 years of age, weighting 103.6 lb, . Rovalcyte dosage: . During the same period patient was treated with SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ). Patient was hospitalized.

5210552-X | Hepatic Enzyme Increased, Hepatic Steatosis
Adverse event was reported on Jan 09, 2007 by a Female patient taking Rovalcyte (View Usage) (Dosage: ) . Location: FRANCE , child 7 years of age, weighting 39.68 lb, Patient had the following side effects: hepatic enzyme increased, hepatic steatosis. During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ), URSOLVAN (View Ursolvan Review and Ursolvan Label ), ADALATE LP (View Adalate Lp Review and Adalate Lp Label ), BACTRIM (View Bactrim Review and Bactrim Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), UVESTEROL (View Uvesterol Review and Uvesterol Label ). Patient was hospitalized.

5193688-1 | Lymphopenia, Neutropenia, White Blood Cell Count Decreased
on Nov 07, 2006 Male patient from FRANCE , 30 years of age, was diagnosed with lung transplant (What is lung transplant?) and was treated with Rovalcyte (View Usage). After Rovalcyte was administered, patient had the following side effects: lymphopenia, neutropenia, white blood cell count decreased. Rovalcyte dosage: . During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), FLAGYL (View Flagyl Review and Flagyl Label ), PROGRAF (View Prograf Review and Prograf Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), ZITHROMAX (View Zithromax Review and Zithromax Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ). Patient was hospitalized.

5161361-1 | Hepatic Enzyme Increased, Hepatic Steatosis
on Aug 28, 2006 Male patient from FRANCE , child 7 years of age, weighting 39.68 lb, was treated with Rovalcyte (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic enzyme increased, hepatic steatosis. Rovalcyte dosage: . During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ), URSOLVAN (View Ursolvan Review and Ursolvan Label ), ADALATE LP (View Adalate Lp Review and Adalate Lp Label ), BACTRIM (View Bactrim Review and Bactrim Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), UVESTEROL (View Uvesterol Review and Uvesterol Label ). Patient was hospitalized.

5150440-0 | Lymphopenia, Neutropenia, White Blood Cell Count Decreased
Patient was taking Rovalcyte (View Usage). Patient had the following side effects: lymphopenia, neutropenia, white blood cell count decreased on Nov 07, 2006 from FRANCE Additional patient health information: Male patient , 30 years of age, was diagnosed with lung transplant (What is lung transplant?) and. Rovalcyte dosage: . During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), FLAGYL (View Flagyl Review and Flagyl Label ), PROGRAF (View Prograf Review and Prograf Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), ZITHROMAX (View Zithromax Review and Zithromax Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ). Patient was hospitalized.

5102865-7 | Agranulocytosis, Diabetes Mellitus, Haemoglobin Decreased, Lymphopenia, Neutropenia, Platelet Count Decreased, Pyrexia
Adverse event was reported on Aug 31, 2006 by a Male patient taking Rovalcyte (View Usage) (Dosage: Unk) was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and. Location: FRANCE , 71 years of age, After Rovalcyte was administered, patient had the following side effects: agranulocytosis, diabetes mellitus, haemoglobin decreased, lymphopenia, neutropenia, platelet count decreased, pyrexia. During the same period patient was treated with TAHOR (Unk) (View Tahor Review and Tahor Label ), MOPRAL (Unk) (View Mopral Review and Mopral Label ), TARDYFERON (Unk) (View Tardyferon Review and Tardyferon Label ), ARANESP (Unk) (View Aranesp Review and Aranesp Label ), PROGRAF (Unk) (View Prograf Review and Prograf Label ), CELLCEPT (Unk) (View Cellcept Review and Cellcept Label ), AMLOR (View Amlor Review and Amlor Label ), DETENSIEL (View Detensiel Review and Detensiel Label ). Patient was hospitalized.

5098838-3 | Hepatic Enzyme Increased, Hepatic Steatosis
on Aug 28, 2006 Male patient from FRANCE , child 7 years of age, weighting 39.68 lb, was treated with Rovalcyte (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic enzyme increased, hepatic steatosis. Rovalcyte dosage: . Patient was hospitalized.

5064758-3 | Anaemia, Condition Aggravated, Mouth Ulceration
on Jul 19, 2006 Female patient from FRANCE , 55 years of age, was diagnosed with anaemia and was treated with Rovalcyte (View Usage). Patient had the following side effects: anaemia, condition aggravated, mouth ulceration. Rovalcyte dosage: Administration On Wednesday And Saturday. The Patient Received 3 To 4 Administrations In Total.. During the same period patient was treated with NEORECORMON (Dosage Increased From 3000 Iu Once A Week To 10000 Iu Twice A Week Due To Worsening Of Anaemia.) (View Neorecormon Review and Neorecormon Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), CERTICAN (View Certican Review and Certican Label ), MIMPARA (View Mimpara Review and Mimpara Label ), ALPRESS (View Alpress Review and Alpress Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), NEORAL (View Neoral Review and Neoral Label ), SOLUPRED (View Solupred Review and Solupred Label ). Patient was hospitalized.

5013840-5 | Agranulocytosis, Bacterial Culture Positive, Chills, Hepatitis A Virus, Pyrexia, Renal Disorder
Patient was taking Rovalcyte (View Usage). After Rovalcyte was administered, patient had the following side effects: agranulocytosis, bacterial culture positive, chills, hepatitis a virus, pyrexia, renal disorder on May 16, 2006 from FRANCE Additional patient health information: Male patient , 56 years of age, was diagnosed with prophylaxis against transplant rejection and. Rovalcyte dosage: . During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), XATRAL (View Xatral Review and Xatral Label ), TENORMIN (View Tenormin Review and Tenormin Label ), SOLUPRED (View Solupred Review and Solupred Label ), DITROPAN (View Ditropan Review and Ditropan Label ). Patient was hospitalized.

4875581-4 | Hallucination, Auditory, Renal Failure Chronic
Adverse event was reported on Dec 07, 2005 by a Male patient taking Rovalcyte (View Usage) (Dosage: ) was diagnosed with viral infection (What is viral infection?), anaemia, chronic lymphocytic leukaemia, aplastic anaemia and. Location: FRANCE , 60 years of age, Patient experienced the following unwanted or unexpected effects: hallucination, auditory, renal failure chronic. During the same period patient was treated with NEORECORMON (View Neorecormon Review and Neorecormon Label ), MABTHERA (View Mabthera Review and Mabthera Label ), VFEND (View Vfend Review and Vfend Label ), ZAVEDOS (View Zavedos Review and Zavedos Label ), GRANOCYTE (View Granocyte Review and Granocyte Label ). Patient was hospitalized.

4768427-6 | Headache, Intracranial Pressure Increased, Papilloedema
on Sep 02, 2005 Female patient from FRANCE , 15 years of age, weighting 85.98 lb, was treated with Rovalcyte (View Usage). Patient had the following side effects: headache (What is headache?), intracranial pressure increased, papilloedema. Rovalcyte dosage: . During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), NEORAL (View Neoral Review and Neoral Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), ASPEGIC 325 (View Aspegic 325 Review and Aspegic 325 Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), SPECIAFOLDINE (View Speciafoldine Review and Speciafoldine Label ), LEDERFOLINE (View Lederfoline Review and Lederfoline Label ), INIPOMP (View Inipomp Review and Inipomp Label ). Patient was hospitalized.

4762726-X | Atrial Flutter
on Aug 26, 2005 Male patient from FRANCE , 33 years of age, was treated with Rovalcyte (View Usage). After Rovalcyte was administered, patient had the following side effects: atrial flutter. Rovalcyte dosage: Reported As 2 Doses Per Day.. During the same period patient was treated with LEXOMIL (0.5 Dose Per Day.) (View Lexomil Review and Lexomil Label ), LASILIX (Reported As 0.5 Dose Per Day.) (View Lasilix Review and Lasilix Label ), CEFUROXIME AXETIL (Reported As 2 Doses Per Day.) (View Cefuroxime Axetil Review and Cefuroxime Axetil Label ), VFEND (Reported As 2 Doses Per Day.) (View Vfend Review and Vfend Label ), CIFLOX (Reported As 2 Doses Per Day.) (View Ciflox Review and Ciflox Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), NEORAL (View Neoral Review and Neoral Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ). Patient was hospitalized.

4645033-5 | Agranulocytosis
Patient was taking Rovalcyte (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis on Feb 08, 2005 from Additional patient health information: Male patient , 45 years of age, weighting 123.5 lb, was diagnosed with antiviral prophylaxis, infection prophylaxis, renal transplant and. Rovalcyte dosage: . During the same period patient was treated with BACTRIM (Treatment Was Discontinued On 24 June 2004 And Re-initiated On 02 July 2004.) (View Bactrim Review and Bactrim Label ), CELLCEPT (Treatment Was Discontinued And Re-initiated On 02 July 2004.) (View Cellcept Review and Cellcept Label ), PROGRAF (View Prograf Review and Prograf Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), MOPRAL (View Mopral Review and Mopral Label ). Patient was hospitalized.

4640121-1 | Agranulocytosis, Pancreatitis Acute, White Blood Cell Count Decreased
Adverse event was reported on Feb 08, 2005 by a Female patient taking Rovalcyte (View Usage) (Dosage: ) was diagnosed with prophylaxis and. Location: , 44 years of age, Patient had the following side effects: agranulocytosis, pancreatitis acute, white blood cell count decreased. During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), PROGRAF (Dosage Regimen Reported As 2.5 Mg Twice.) (View Prograf Review and Prograf Label ), CORTICOIDS NOS (View Corticoids Nos Review and Corticoids Nos Label ). Patient was hospitalized.

4588243-8 | Agranulocytosis
on Feb 08, 2005 Female patient from , 44 years of age, was diagnosed with prophylaxis and was treated with Rovalcyte (View Usage). After Rovalcyte was administered, patient had the following side effects: agranulocytosis. Rovalcyte dosage: . During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), PROGRAF (Dosage Regimen Reported As 2.5 Mg Twice.) (View Prograf Review and Prograf Label ), CORTICOIDS NOS (View Corticoids Nos Review and Corticoids Nos Label ).

4584094-9 | Agranulocytosis
on Feb 04, 2005 Female patient from , 26 years of age, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and was treated with Rovalcyte (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis. Rovalcyte dosage: . During the same period patient was treated with PIRILENE (View Pirilene Review and Pirilene Label ), RIFADIN (View Rifadin Review and Rifadin Label ), MYAMBUTOL (View Myambutol Review and Myambutol Label ), RIMIFON (View Rimifon Review and Rimifon Label ), VIDEX (View Videx Review and Videx Label ), EPIVIR (View Epivir Review and Epivir Label ), BACTRIM DS (Treatment Re-introduced On 3 Jan 2005.) (View Bactrim Ds Review and Bactrim Ds Label ). Patient was hospitalized.

4549543-0 | Blood Creatinine Increased
Patient was taking Rovalcyte (View Usage). Patient had the following side effects: blood creatinine increased on Jan 03, 2005 from Additional patient health information: Male patient , 58 years of age, . Rovalcyte dosage: . During the same period patient was treated with FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ). Patient was hospitalized.